IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 359 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,159 | -99.9% | 30,706 | -1.9% | 0.00% | 0.0% |
| Q3 2022 | $1,384,000 | +71.3% | 31,306 | +74.1% | 0.00% | +100.0% |
| Q1 2021 | $808,000 | -42.8% | 17,977 | -28.1% | 0.00% | -66.7% |
| Q4 2020 | $1,413,000 | +34.4% | 24,986 | +12.8% | 0.00% | 0.0% |
| Q3 2020 | $1,051,000 | -12.4% | 22,151 | +8.9% | 0.00% | 0.0% |
| Q2 2020 | $1,200,000 | +39.0% | 20,346 | +11.6% | 0.00% | 0.0% |
| Q1 2020 | $863,000 | -38.8% | 18,235 | -22.0% | 0.00% | +50.0% |
| Q4 2019 | $1,411,000 | +10.0% | 23,369 | +9.1% | 0.00% | -33.3% |
| Q3 2019 | $1,283,000 | -51.4% | 21,420 | -47.8% | 0.00% | +200.0% |
| Q2 2019 | $2,638,000 | +65850.0% | 41,046 | +87231.9% | 0.00% | – |
| Q1 2019 | $4,000 | – | 47 | +840.0% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 5 | -99.2% | 0.00% | – |
| Q2 2016 | $15,000 | -44.4% | 663 | +0.6% | 0.00% | – |
| Q1 2016 | $27,000 | – | 659 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |